Emidio Decarolis

Emidio DeCarolis is an Owner of Vitesse Transport Corporation which is an asset based Pharmaceutical & Healthcare Road Transportation Carrier. Emidio joined Vitesse Transportation Corporation, a Company which he started with his Partners, in a full-time capacity in 2015, and lead Vitesse Trucking Operations. Vitesse possesses over 100 trucks and 300 trailers. In 2019, Emidio. together with his Partner, established Vitesse Pharmaceutical & Healthcare Division to provide qualified road transportation services to the Pharmaceutical and Healthcare sectors in the US, Mexico and Canada. By early 2021, Vitesse Pharmaceutical and Healthcare Division occupied over 50% of Vitesse trucks and trailers assets in order to better serve their healthcare customers. Emidio and the Vitesse Pharmaceutical & Healthcare Team, began to independently build our Temperature Management, Regulatory Compliance, Quality Assurance, Information Technology, Security and Sustainability capabilities. Over the last three years, Emidio and his Partner have primarily focused on growing the Vitesse Pharmaceutical & Healthcare Road Transportation business organically, building our Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) capabilities and expanding our Pharma Road Transportation Network in North America. Emidio holds a Ph.D. in Biochemistry & Molecular Biology and was a Postdoctoral Research Fellow at Merck Research Laboratories. Emidio has maintained increasing roles and responsibilities in Drug Discovery, Clinical Research, Research & Development, Regulatory, Quality Compliance and Business Development at Merck and Pfizer. Emidio played an important role in the R&D of Gardasil 9 and the Regulatory filing in Canada.